Accent Microcell Limited (NSE:ACCENTMIC)

Market Cap	14.51B +123.9%
Revenue (ttm)	3.50B +32.0%
Net Income	438.59M +32.7%
EPS	18.65 +25.1%
Shares Out	23.99M
PE Ratio	32.44
Forward PE	n/a
Dividend	1.00 (0.17%)
Ex-Dividend Date	Jul 17, 2026

Volume	65,000
Open	608.95
Previous Close	598.30
Day's Range	593.00 - 608.95
52-Week Range	238.00 - 608.95
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Accent Microcell

Accent Microcell Limited manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally. The company offers microcrystalline cellulose, powdered cellulose, microcrystalline cellulose spheres, silicified microcrystalline cellulose, crosscarmellose sodium, magnesium stearate, sodium starch glycolate, carboxymethyl cellulose, and microcrystalline cellulose with carboxy methyl cellulose. It also provides services, including supply chain management, on-time material delivery, customer assis...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2001
• Employees: 260
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACCENTMIC

Financial Performance

In fiscal year 2026, Accent Microcell's revenue was 3.50 billion, an increase of 32.03% compared to the previous year's 2.65 billion. Earnings were 438.59 million, an increase of 32.65%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error